UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insights into European drug shortages: a survey of hospital pharmacists

PloS one, 2015-03, Vol.10 (3), p.e0119322-e0119322

2015

Volltextzugriff (PDF)

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study

PloS one, 2017-03, Vol.12 (3), p.e0174556

2017

Volltextzugriff (PDF)

High-risk medication in community care: a scoping review

European journal of clinical pharmacology, 2020-05, Vol.76 (5), p.623-638

2020

Volltextzugriff (PDF)

Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

Clinical cancer research, 2018-05, Vol.24 (10), p.2312-2318

2018

Volltextzugriff (PDF)

Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey

BMC medical informatics and decision making, 2022-02, Vol.22 (1), p.48-48, Article 48

2022

Volltextzugriff (PDF)

Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

BMC medical informatics and decision making, 2019-02, Vol.19 (1), p.29-29, Article 29

2019

Volltextzugriff (PDF)

From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis

BMJ open, 2022-04, Vol.12 (4), p.e053010-e053010

2022

Volltextzugriff (PDF)

Home care nurses’ management of high-risk medications: a cross-sectional study

Journal of pharmaceutical policy and practice, 2022-11, Vol.15 (1), p.1-88, Article 88

2022

Volltextzugriff (PDF)

Time Investment in Drug Supply Problems by Flemish Community Pharmacies

Frontiers in pharmacology, 2017-08, Vol.8, p.568-568

2017

Volltextzugriff (PDF)

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective

Frontiers in medicine, 2020-02, Vol.7, p.33-33

2020

Volltextzugriff (PDF)

Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward

Computational and structural biotechnology journal, 2023, Vol.22, p.58-65

2023

Volltextzugriff (PDF)

Breakdown of 2-Hydroxylated Straight Chain Fatty Acids via Peroxisomal 2-Hydroxyphytanoyl-CoA Lyase

The Journal of biological chemistry, 2005-03, Vol.280 (11), p.9802-9812

2005

Volltextzugriff (PDF)

Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

Frontiers in pharmacology, 2017-04, Vol.8, p.171-171

2017

Volltextzugriff (PDF)

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

BMC health services research, 2014-09, Vol.14 (1), p.438-438, Article 438

2014

Volltextzugriff (PDF)

Adult Refsum Disease: A Form of Tapetoretinal Dystrophy Accessible to Therapy

Survey of ophthalmology, 2010-11, Vol.55 (6), p.531-538

2010

Volltextzugriff (PDF)

Meropenem –valproic acid interaction in patients with cefepime-associated status epilepticus

American journal of health-system pharmacy, 2007-01, Vol.64 (1), p.54-58

2007

Volltextzugriff (PDF)

Financial based agreements and performance based agreements: the Belgian experience

Journal of pharmaceutical policy and practice, 2015-10, Vol.8 (S1), p.O1-O1, Article O1

2015

Volltextzugriff (PDF)

Clinical, Economic and Policy Implications of Drug Shortages in the European Union

Applied health economics and health policy, 2017-08, Vol.15 (4), p.441-445

2017

Volltextzugriff (PDF)

Toward a European definition for a drug shortage: a qualitative study

Frontiers in pharmacology, 2015, Vol.6, p.253-253

2015

Volltextzugriff (PDF)

Causes of drug shortages in the legal pharmaceutical framework

Regulatory toxicology and pharmacology, 2015-03, Vol.71 (2), p.251-258

2015

Volltextzugriff (PDF)

Purification, Molecular Cloning, and Expression of 2-Hydroxyphytanoyl-CoA Lyase, a Peroxisomal Thiamine Pyrophosphate-Dependent Enzyme that Catalyzes the Carbon-Carbon Bond Cleavage during α -Oxidation of 3-Methyl-Branched Fatty Acids

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (18), p.10039-10044

1999

Volltextzugriff (PDF)

The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis

Journal of medical systems, 2024-09, Vol.48 (1), p.93, Article 93

2024

Volltextzugriff (PDF)

High-Risk Medication in Home Care Nursing: A Delphi Study

Journal of patient safety, 2022-08, Vol.18 (5), p.435-443

2022

Volltextzugriff (PDF)

Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012

Orphanet journal of rare diseases, 2017-02, Vol.12 (1), p.36-36, Article 36

2017

Volltextzugriff (PDF)

The necessity for a European definition of drug shortages

The International journal of pharmacy practice, 2018-08, Vol.26 (4), p.289-290

2018

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(68)
Berichte
(1)

Sprache

Englisch
(69)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Insights into European drug shortages: a survey of hospital pharmacists

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study

High-risk medication in community care: a scoping review

Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial

Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey

Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis

Home care nurses’ management of high-risk medications: a cross-sectional study

Time Investment in Drug Supply Problems by Flemish Community Pharmacies

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective

Bedside check of medication appropriateness (BED-CMA) as a risk-based tool for bedside clinical pharmacy services: A proof-of-concept study at the trauma surgery ward

Breakdown of 2-Hydroxylated Straight Chain Fatty Acids via Peroxisomal 2-Hydroxyphytanoyl-CoA Lyase

Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

Adult Refsum Disease: A Form of Tapetoretinal Dystrophy Accessible to Therapy

Meropenem –valproic acid interaction in patients with cefepime-associated status epilepticus

Financial based agreements and performance based agreements: the Belgian experience

Clinical, Economic and Policy Implications of Drug Shortages in the European Union

Toward a European definition for a drug shortage: a qualitative study

Causes of drug shortages in the legal pharmaceutical framework

Purification, Molecular Cloning, and Expression of 2-Hydroxyphytanoyl-CoA Lyase, a Peroxisomal Thiamine Pyrophosphate-Dependent Enzyme that Catalyzes the Carbon-Carbon Bond Cleavage during α -Oxidation of 3-Methyl-Branched Fatty Acids

The Impact of Customized Screening Intervals on the Burden of Drug-Drug Interaction Alerts: An Interrupted Time Series Analysis

High-Risk Medication in Home Care Nursing: A Delphi Study

Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012

The necessity for a European definition of drug shortages

Suchergebnisse filtern